These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

53 related articles for article (PubMed ID: 3865888)

  • 21. [Persisting hyperlipidemias as risk factors of diabetic macroangiopathy].
    Vogelberg KH; Meurers G
    Klin Wochenschr; 1986 Jun; 64(11):506-11. PubMed ID: 3523028
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Serum lipids and lipoproteins in 157 insulin dependent diabetic children and adolescents in relation to metabolic regulation, obesity and genetic hyperlipoproteinemia.
    Andersen GE; Christiansen JS; Mortensen HB; Christiansen KM; Pedersen-Bjergaard L; Kastrup KW; Vestermark S
    Acta Paediatr Scand; 1983 May; 72(3):361-5. PubMed ID: 6349244
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Metabolic control and the prevalence of dyslipidemia in children and adolescents with insulin-dependent diabetes mellitus].
    Torres Tamayo M; Lerman Garber I; Bravo Ríos LE; Cardoso Saldaña G; Mendoza Morfín F; Zamora González J; Montero González P; Junco Lorenzana E; Posadas Romero C
    Rev Invest Clin; 1993; 45(6):545-52. PubMed ID: 8159874
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Hyperlipoproteinemias in diabetes mellitus].
    Slavina LS; Romanovskaia GA; Kantordzhan IG; Mazovetskiĭ AG; Riazanovskaia IV
    Probl Endokrinol (Mosk); 1983; 29(3):17-21. PubMed ID: 6866949
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Serum lipid and lipoprotein levels in long-term insulin-dependent diabetes mellitus. Relation to residual insulin secretion, microvascular lesions and environmental factors.
    Sjöberg S; Gunnarsson R; Rössner S; Ostman J
    Acta Med Scand; 1987; 222(5):445-51. PubMed ID: 3321927
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [The phenotypic characteristics and incidence of dyslipoproteinemias in diabetic patients].
    Kiriakov A; Koev D; Kavrykova Iu; Dimova Ia; Ovcharova N; Taneva T; Tinterova Z; Borisova A; Tsoneva G
    Probl Endokrinol (Mosk); 1990; 36(6):25-9. PubMed ID: 2087461
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Dietetics and the prevention of hyperlipoproteinemias].
    Oromi Durich J; Coronas Alonso R; Canela Arqués R; González Fusté F
    Rev Sanid Hig Publica (Madr); 1986; 60(11-12):1109-18. PubMed ID: 3629153
    [No Abstract]   [Full Text] [Related]  

  • 28. Intraplatelet serotonin in patients with diabetes mellitus and peripheral vascular disease.
    Barradas MA; Gill DS; Fonseca VA; Mikhailidis DP; Dandona P
    Eur J Clin Invest; 1988 Aug; 18(4):399-404. PubMed ID: 3139426
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Insulin response to oral glucose in patients with a previous myocardial infarction and in patients with peripheral vascular disease. Hyperinsulinism and its relationships to hypertriglyceridemia and overweight.
    Sorge F; Schwartzkopff W; Neuhaus GA
    Diabetes; 1976 Jul; 25(7):586-94. PubMed ID: 1278607
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Altered low density lipoproteins in peripheral vascular disease patients.
    David JS; Reichle RM; Reichle FA
    J Surg Res; 1986 Nov; 41(5):538-42. PubMed ID: 3773511
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Plasma lipid and lipoprotein disorders in IDDM.
    Dunn FL
    Diabetes; 1992 Oct; 41 Suppl 2():102-6. PubMed ID: 1526327
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Hyperlipoproteinemias and heart disease. A clinician's guide.
    Weinsier RL
    Ala J Med Sci; 1987 Oct; 24(4):420-6. PubMed ID: 3310708
    [No Abstract]   [Full Text] [Related]  

  • 33. [Use of miscleron on diabetes mellitus patients with peripheral circulatory disorders].
    Kakhnovskiĭ IM Paskalov ES; Grishina IM; Sokolov IIu
    Probl Endokrinol (Mosk); 1974; 20(3):16-20. PubMed ID: 4217894
    [No Abstract]   [Full Text] [Related]  

  • 34. Dyslipidemias in patients with diabetes mellitus: classification and risks and benefits of therapy.
    Oki JC
    Pharmacotherapy; 1995; 15(3):317-37. PubMed ID: 7667166
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effects of insulin on body composition in patients with insulin-dependent and non-insulin-dependent diabetes.
    Sinha A; Formica C; Tsalamandris C; Panagiotopoulos S; Hendrich E; DeLuise M; Seeman E; Jerums G
    Diabet Med; 1996 Jan; 13(1):40-6. PubMed ID: 8741811
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Disorders of lipid metabolism in diabetes mellitus].
    Biesenbach G
    Wien Med Wochenschr Suppl; 1989; 105():9-17. PubMed ID: 2694631
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Hypertriglyceridemia in insulin dependent diabetes mellitus with peripheral vascular disease.
    Vogelberg KH; Grimm K; Gries FA
    Horm Metab Res Suppl; 1985; 15():90-4. PubMed ID: 3865888
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pharmacodynamic effects of oral contraceptive steroids on biochemical markers for arterial thrombosis. Studies in non-diabetic women and in women with insulin-dependent diabetes mellitus.
    Petersen KR
    Dan Med Bull; 2002 Feb; 49(1):43-60. PubMed ID: 11894723
    [TBL] [Abstract][Full Text] [Related]  

  • 39.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.